T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.

In the murine model of Leishmania major infection, resistance or susceptibility to the parasite has been associated with the development of a Th1 or Th2 type of immune response. Recently, however, the immunosuppressive effects of IL-10 have been ascribed a crucial role in the development of the diff...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tobias Schwarz, Katharina A Remer, Wiebke Nahrendorf, Anita Masic, Lisa Siewe, Werner Müller, Axel Roers, Heidrun Moll
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
Acceso en línea:https://doaj.org/article/a045dda4dbae44f1a551cd0e1d5eb9e7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a045dda4dbae44f1a551cd0e1d5eb9e7
record_format dspace
spelling oai:doaj.org-article:a045dda4dbae44f1a551cd0e1d5eb9e72021-11-18T06:05:27ZT cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.1553-73661553-737410.1371/journal.ppat.1003476https://doaj.org/article/a045dda4dbae44f1a551cd0e1d5eb9e72013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23825956/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374In the murine model of Leishmania major infection, resistance or susceptibility to the parasite has been associated with the development of a Th1 or Th2 type of immune response. Recently, however, the immunosuppressive effects of IL-10 have been ascribed a crucial role in the development of the different clinical correlates of Leishmania infection in humans. Since T cells and professional APC are important cellular sources of IL-10, we compared leishmaniasis disease progression in T cell-specific, macrophage/neutrophil-specific and complete IL-10-deficient C57BL/6 as well as T cell-specific and complete IL-10-deficient BALB/c mice. As early as two weeks after infection of these mice with L. major, T cell-specific and complete IL-10-deficient animals showed significantly increased lesion development accompanied by a markedly elevated secretion of IFN-γ or IFN-γ and IL-4 in the lymph nodes draining the lesions of the C57BL/6 or BALB/c mutants, respectively. In contrast, macrophage/neutrophil-specific IL-10-deficient C57BL/6 mice did not show any altered phenotype. During the further course of disease, the T cell-specific as well as the complete IL-10-deficient BALB/c mice were able to control the infection. Furthermore, a dendritic cell-based vaccination against leishmaniasis efficiently suppresses the early secretion of IL-10, thus contributing to the control of parasite spread. Taken together, IL-10 secretion by T cells has an influence on immune activation early after infection and is sufficient to render BALB/c mice susceptible to an uncontrolled Leishmania major infection.Tobias SchwarzKatharina A RemerWiebke NahrendorfAnita MasicLisa SieweWerner MüllerAxel RoersHeidrun MollPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 9, Iss 6, p e1003476 (2013)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Tobias Schwarz
Katharina A Remer
Wiebke Nahrendorf
Anita Masic
Lisa Siewe
Werner Müller
Axel Roers
Heidrun Moll
T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.
description In the murine model of Leishmania major infection, resistance or susceptibility to the parasite has been associated with the development of a Th1 or Th2 type of immune response. Recently, however, the immunosuppressive effects of IL-10 have been ascribed a crucial role in the development of the different clinical correlates of Leishmania infection in humans. Since T cells and professional APC are important cellular sources of IL-10, we compared leishmaniasis disease progression in T cell-specific, macrophage/neutrophil-specific and complete IL-10-deficient C57BL/6 as well as T cell-specific and complete IL-10-deficient BALB/c mice. As early as two weeks after infection of these mice with L. major, T cell-specific and complete IL-10-deficient animals showed significantly increased lesion development accompanied by a markedly elevated secretion of IFN-γ or IFN-γ and IL-4 in the lymph nodes draining the lesions of the C57BL/6 or BALB/c mutants, respectively. In contrast, macrophage/neutrophil-specific IL-10-deficient C57BL/6 mice did not show any altered phenotype. During the further course of disease, the T cell-specific as well as the complete IL-10-deficient BALB/c mice were able to control the infection. Furthermore, a dendritic cell-based vaccination against leishmaniasis efficiently suppresses the early secretion of IL-10, thus contributing to the control of parasite spread. Taken together, IL-10 secretion by T cells has an influence on immune activation early after infection and is sufficient to render BALB/c mice susceptible to an uncontrolled Leishmania major infection.
format article
author Tobias Schwarz
Katharina A Remer
Wiebke Nahrendorf
Anita Masic
Lisa Siewe
Werner Müller
Axel Roers
Heidrun Moll
author_facet Tobias Schwarz
Katharina A Remer
Wiebke Nahrendorf
Anita Masic
Lisa Siewe
Werner Müller
Axel Roers
Heidrun Moll
author_sort Tobias Schwarz
title T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.
title_short T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.
title_full T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.
title_fullStr T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.
title_full_unstemmed T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.
title_sort t cell-derived il-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/a045dda4dbae44f1a551cd0e1d5eb9e7
work_keys_str_mv AT tobiasschwarz tcellderivedil10determinesleishmaniasisdiseaseoutcomeandissuppressedbyadendriticcellbasedvaccine
AT katharinaaremer tcellderivedil10determinesleishmaniasisdiseaseoutcomeandissuppressedbyadendriticcellbasedvaccine
AT wiebkenahrendorf tcellderivedil10determinesleishmaniasisdiseaseoutcomeandissuppressedbyadendriticcellbasedvaccine
AT anitamasic tcellderivedil10determinesleishmaniasisdiseaseoutcomeandissuppressedbyadendriticcellbasedvaccine
AT lisasiewe tcellderivedil10determinesleishmaniasisdiseaseoutcomeandissuppressedbyadendriticcellbasedvaccine
AT wernermuller tcellderivedil10determinesleishmaniasisdiseaseoutcomeandissuppressedbyadendriticcellbasedvaccine
AT axelroers tcellderivedil10determinesleishmaniasisdiseaseoutcomeandissuppressedbyadendriticcellbasedvaccine
AT heidrunmoll tcellderivedil10determinesleishmaniasisdiseaseoutcomeandissuppressedbyadendriticcellbasedvaccine
_version_ 1718424622430420992